Semax
Also known as: ACTH(4-10) analogue
Semax is a synthetic peptide developed in Russia, derived from a fragment of adrenocorticotropic hormone (ACTH). It is studied chiefly for reported cognitive and neuroprotective effects and is not approved for human use in Australia.
- Category
- Cognitive / Nootropic
- Reported half-life
- Not well established
- Common forms
- Lyophilised powder for reconstitution, Nasal drops (research preparations)
- Research status
- Developed in Russia and studied there for stroke and cognitive indications; not approved for human use in Australia. Evidence outside regional studies is limited.
- Last updated
- 21 June 2026
Claimed effects
The following effects are reported or claimed by users and in early research. They are not established medical facts and many are not supported by large human trials.
- Reported to have nootropic (cognitive-enhancing) effects in early research
- Studied for possible neuroprotective effects after ischaemic events
- Reported to influence attention, memory and mood
- Reported to affect BDNF and other neurotrophic signalling
How it is reported to work
Semax is proposed to act as a stabilised analogue of the ACTH(4-10) fragment, without the hormonal corticotropic activity of full ACTH. Reported mechanisms include modulation of brain-derived neurotrophic factor (BDNF), the dopaminergic and serotonergic systems, and protection of neurons under stress. These proposals derive mainly from animal and small Russian human studies and should be considered preliminary.
Background
Semax is a synthetic peptide based on a short fragment of adrenocorticotropic hormone (ACTH), modified so that it lacks the usual hormonal activity. It was developed in Russia, where it has been studied in cognitive and stroke-related contexts. This page is educational information, not medical advice, and the effects below are reported claims rather than established facts.
What the research shows
Published Semax research is dominated by animal studies and small human trials conducted in Russia. These suggest possible cognitive and neuroprotective effects, but the evidence base is limited and has not been confirmed in large international trials.
| Evidence type | Status |
|---|---|
| Animal studies | Present |
| Small regional human studies | Some |
| Large international trials | Lacking |
| Australian approval | None |
What people use it for (reported)
Online, people report interest in Semax for focus, memory and mental clarity. These are anecdotal reports, not validated clinical outcomes. Reported benefits should not be interpreted as proven, and nothing here is encouragement to use it.
Things to be aware of
Semax is not approved for human use in Australia. Its long-term safety in humans is not well established, and grey-market preparations cannot be verified for purity or identity. If you have cognitive or neurological concerns, the right step is to consult a qualified healthcare professional. This article does not recommend obtaining or using Semax.
Reported positives & side effects
Compiled from research and community reports. These are reported outcomes, not guarantees or medical advice, individual experiences vary widely.
Reported positives
- Reported improvement in focus and mental clarity
- Reported support for memory and learning in early research
- Reported mood lift and reduced mental fatigue
- Reported neuroprotective interest in stroke-related research
- Reported as stimulating without typical stimulant jitter
Common side effects
- Nasal irritation or congestion reported with nasal-drop forms
- Headache reported by some users
- Overstimulation or restlessness reported
- Altered sleep reported when used late in the day
Rare / serious side effects
- Allergic or hypersensitivity reactions reported
- Unexpected mood or anxiety changes reported
- Unknown long-term effects from unverified grey-market product
Reported misuse & overdose risks
What has been reported to happen with overuse, excessive dosing, or long-term misuse of Semax. Listed so you can make an informed decision, not to suggest any use is safe.
- Reported dosing well above amounts used in Russian studies seeking stronger stimulation
- Reported use of unverified grey-market product with uncertain identity and purity
- Reported daily long-term use without breaks or monitoring
- Reported stacking with multiple stimulant nootropics, risking overstimulation
Reported results timeline
Roughly how long people report it takes to notice effects. A general guide from reports, not a promise, and not advice. Focus and alertness effects are reported as fast, often the same day, with cognitive and mood benefits reported accumulating over one to three weeks.
First effects
Reported focus and alertness within hours of the same day
Noticeable change
Reported steadier focus and mood over days
Clear results
Reported cumulative cognitive benefits
Commonly reported dosing & protocol
Reported figures only, NOT a recommendation or dosing advice. These are numbers people report using, compiled for education so you can make an informed decision. We do not advise anyone to take Semax. Many peptides are not approved for human use in Australia. Speak to a qualified healthcare professional.
| Route | Intranasal |
|---|---|
| Typical reported dose | Reported as roughly 200-600 mcg per day, with higher amounts reported for 1% solutions |
| Frequency | Reported as once or twice daily |
| Cycle length | Reported in short courses of a few weeks, sometimes cycled with breaks; not standardised |
Commonly reported as intranasal dosing over short courses of a few weeks, sometimes cycled with breaks; reported patterns vary and are not standardised. This is reported information, not advice.
Best used with / commonly stacked with
Combinations people report using together. Reported, not recommended, stacking can increase risks.
Reported frequently paired so calming Selank balances stimulating Semax
Noopept
Reported combined for additive cognitive effects
Reported discussed together within neuroprotective stacks
Safety notes
Semax is not approved for human use in Australia and its long-term safety in humans is not well characterised. Grey-market product identity and purity cannot be verified by consumers. Anyone with a health concern should consult a qualified healthcare professional rather than self-experiment.